Bacilli in the context of "Italics"

Play Trivia Questions online!

or

Skip to study material about Bacilli in the context of "Italics"

Ad spacer

⭐ Core Definition: Bacilli

Bacilli is a taxonomic class of bacteria that includes two orders, Bacillales and Lactobacillales, which contain several well-known pathogens such as Bacillus anthracis (the cause of anthrax). Bacilli are almost exclusively gram-positive bacteria.

The name Bacillus, capitalized and italicized, refers to a specific genus of bacteria. The name Bacilli, capitalized but not italicized, can also refer to a less specific taxonomic group of bacteria that includes two orders, one of which contains the genus Bacillus. When the word is formatted with lowercase and not italicized, 'bacillus', it will most likely be referring to shape and not to the genus at all.

↓ Menu

>>>PUT SHARE BUTTONS HERE<<<
In this Dossier

Bacilli in the context of Alexandre Yersin

Alexandre Émile John Yersin (22 September 1863 – 1 March 1943) was a Swiss-French physician and bacteriologist. He is remembered for his work as a pioneer in microbiology and immunology. Yersin is the co-discoverer of both the Diphtheria and Tetanus toxins (1890 with Émile Roux) and of the bacillus responsible for the bubonic plague or pest (1894, with Kitasato Shibasaburō). The bacteria was later named in his honour: Yersinia pestis. Yersin also demonstrated for the first time that the same bacillus was present in the rodent as well as in the human disease, thus underlining the possible means of transmission.

↑ Return to Menu

Bacilli in the context of Neomycin

Neomycin, also known as framycetin, is an aminoglycoside antibiotic that displays bactericidal activity against Gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against Gram-positive bacilli and anaerobic Gram-negative bacilli. Neomycin comes in oral and topical formulations, including creams, ointments, and eyedrops. Neomycin belongs to the aminoglycoside class of antibiotics that contain two or more amino sugars connected by glycosidic bonds.

Neomycin was discovered in 1949 by microbiologist Selman Waksman and his student Hubert Lechevalier at Rutgers University. Neomycin received approval for medical use in 1952. Rutgers University was granted the patent for neomycin in 1957.

↑ Return to Menu